title: Lung transplantation and extracorporeal photopheresis: The answer to bronchiolitis obliterans?
abstract: Bronchiolitis obliterans (BO) is a rare condition characterized by narrowing of small airways. Although it can be caused by variety of conditions, most cases occur after lung and bone marrow transplantation in the form of graft-versus-host-disease and chronic rejection, respectively. Extracorporeal photopheresis (ECP) has emerged as a promising treatment for the condition, especially for BO after lung transplantation. Available data suggest that around two-thirds of patients may demonstrate either slowing or cessation of disease progression after treatment with ECP. Recent researches also provide interesting insights into possible mechanism of action of ECP in BO.
authors.affiliation: University of California San Diego, 9444 Medical Center Drive, 3-030, La Jolla, CA 92037, USA. Electronic address: gyung@ucsd.edu.
authors.forename: Gordon L
authors.initials: GL
authors.lastname: Yung
authors.affiliation: University of California San Diego, 9444 Medical Center Drive, 3-030, La Jolla, CA 92037, USA.
authors.forename: Vanessa
authors.initials: V
authors.lastname: Craig
mesh_terms: D000818:Animals; D016026:Bone Marrow Transplantation / Q000009:adverse effects; D001989:Bronchiolitis Obliterans / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D018450:Disease Progression; D006084:Graft Rejection / Q000628:therapy; D006086:Graft vs Host Disease / Q000628:therapy; D006801:Humans; D056747:Immunomodulation; D016040:Lung Transplantation / Q000009:adverse effects*; D017893:Photopheresis / Q000379:methods*; D012107:Research Design; D013601:T-Lymphocytes / Q000166:cytology; D016896:Treatment Outcome